Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Wack format. I wasn't attempting a popup video. smh
View:
Post by C10H12N2 on Jun 28, 2022 1:44am

Wack format. I wasn't attempting a popup video. smh

Yeah Whalewatcher1. It raises more questions than answers. What's worse is no one on any message board has any solid info to share. That's even wacker! People are tuned out of the process or still shell shocked by all the carnage left in the wake of managment decisions. Worse case scenario is they are positioning the company for bankruptcy and somehow Kulwant Malhi gets everything handed to him on the cheap. i wouildn't put it past them at HQ. They surrendered the FAIMS device after all for absolutely nothing in return. Who benefited from that move...Cannabix Technologies Inc. Who knows what they have cooking up their sleeves now. The numbers thus far do not add up and nobody knows if Nasdaq is still in play. What's certain is DILUTION if it's not a belly up situation.
Be the first to comment on this post
Algernon Pharmaceuticals Inc.